Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Asadullah

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Experimental Dermatology|August 19, 2000
IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progressionK Asadullah, A Haeussler-Quade, S Gellrich, et al.
The Journal of Investigative Dermatology|May 12, 2001
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findingsK Asadullah, M Friedrich, S Hanneken, et al.
British Journal of Pharmacology|May 9, 2009
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseasesH Schäcke, T M Zollner, W D Döcke, et al.
The British Journal of Dermatology|August 23, 2003
Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasisP Hensen, K Asadullah, C Windemuth, et al.
Nature Medicine|July 14, 1998
Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injuryC Woiciechowsky, K Asadullah, D Nestler, et al.
The British Journal of Dermatology|June 6, 2003
Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitisW-D Döcke, C Kiessling, M Worm, et al.
Clinical and Experimental Immunology|December 8, 2007
Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell typeC Schoenbein, W-D Docke, K Wolk, et al.
Genes and Immunity|July 24, 2015
Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanismsS von Haehling, K Wolk, C Höflich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
Archives of Internal Medicine|February 24, 1997
Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principleW J Kox, R C Bone, D Krausch, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Experimental Dermatology|August 19, 2000
IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progressionK Asadullah, A Haeussler-Quade, S Gellrich, et al.
The Journal of Investigative Dermatology|May 12, 2001
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findingsK Asadullah, M Friedrich, S Hanneken, et al.
British Journal of Pharmacology|May 9, 2009
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseasesH Schäcke, T M Zollner, W D Döcke, et al.
The British Journal of Dermatology|August 23, 2003
Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasisP Hensen, K Asadullah, C Windemuth, et al.
Nature Medicine|July 14, 1998
Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injuryC Woiciechowsky, K Asadullah, D Nestler, et al.
The British Journal of Dermatology|June 6, 2003
Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitisW-D Döcke, C Kiessling, M Worm, et al.
Clinical and Experimental Immunology|December 8, 2007
Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell typeC Schoenbein, W-D Docke, K Wolk, et al.
Genes and Immunity|July 24, 2015
Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanismsS von Haehling, K Wolk, C Höflich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2023
Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST studyS Gerdes, M Hoffmann, K Asadullah, et al.
Archives of Internal Medicine|February 24, 1997
Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principleW J Kox, R C Bone, D Krausch, et al.
Pageof 7